Wire Stories
Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer
HOUSTON–(BUSINESS WIRE)–ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that Dr....